Abstract
The mechanism for ingenious tissue regeneration in mammals is roughly divided into two distinct systems. One is a system in which undifferentiated, vigorously proliferative stem cells assume the principal role in tissue regeneration. It operates to regenerate and repair tissues comprising differentiated cells that are no longer capable of proliferation, such as the hemopoietic tissue of bone marrow, nerve tissues and muscles. The other, termed the simple duplication system, is the regeneration for tissues whose cellular components are mature and differentiated, yet vitally capable of proliferation as seen in the regeneration of parenchymal organs such as the liver, kidney, and lung. Therefore, for organs with complicated multi-cellular architecture such as the liver, kidney, and lung, treatment of an injury by activation of simple duplication system will be a means of therapy in accordance with nature.
Keywords: HGF, Met, NK4, simple duplication, epithelial growth factor receptor, gene therapy, peripheral artery disease (PAD), c-Met, SHIP-2, plasmid DNA transfer, Phase III clinical trial, EPCs, Cbl, ROS, VSMC, CLI, Ang II, fibroblast growth factor, senescence, GTP binding rac1, Rutherford 5, ERK, Akt, ankle-brachial pressure index, QOL
Current Signal Transduction Therapy
Title: Introduction: Hepatocyte Growth Factor and Met Receptor, from Discovery to Therapeutic Implications
Volume: 6 Issue: 2
Author(s): Toshikazu Nakamura
Affiliation:
Keywords: HGF, Met, NK4, simple duplication, epithelial growth factor receptor, gene therapy, peripheral artery disease (PAD), c-Met, SHIP-2, plasmid DNA transfer, Phase III clinical trial, EPCs, Cbl, ROS, VSMC, CLI, Ang II, fibroblast growth factor, senescence, GTP binding rac1, Rutherford 5, ERK, Akt, ankle-brachial pressure index, QOL
Abstract: The mechanism for ingenious tissue regeneration in mammals is roughly divided into two distinct systems. One is a system in which undifferentiated, vigorously proliferative stem cells assume the principal role in tissue regeneration. It operates to regenerate and repair tissues comprising differentiated cells that are no longer capable of proliferation, such as the hemopoietic tissue of bone marrow, nerve tissues and muscles. The other, termed the simple duplication system, is the regeneration for tissues whose cellular components are mature and differentiated, yet vitally capable of proliferation as seen in the regeneration of parenchymal organs such as the liver, kidney, and lung. Therefore, for organs with complicated multi-cellular architecture such as the liver, kidney, and lung, treatment of an injury by activation of simple duplication system will be a means of therapy in accordance with nature.
Export Options
About this article
Cite this article as:
Nakamura Toshikazu, Introduction: Hepatocyte Growth Factor and Met Receptor, from Discovery to Therapeutic Implications, Current Signal Transduction Therapy 2011; 6 (2) . https://dx.doi.org/10.2174/157436211795659937
DOI https://dx.doi.org/10.2174/157436211795659937 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Meet Our Regional Editor
Current Vascular Pharmacology Circulating Endothelial Progenitor Cells Characterization, Function and Relationship with Cardiovascular Risk Factors
Current Pharmaceutical Design The Heart and Brain Imaging in Lone Atrial Fibrillation – Are We Surprised?
Current Pharmaceutical Design The ABCA2 Transporter: Intracellular Roles in Trafficking and Metabolism of LDL-Derived Cholesterol and Sterol-Related Compounds
Current Drug Metabolism B-Type Natriuretic Peptide for Diagnosis and Therapy
Recent Patents on Cardiovascular Drug Discovery Life-history Constraints on the Mechanisms that Control the Rate of ROS Production
Current Genomics Pharmacological Therapy in Children with Atrial Fibrillation and Atrial Flutter
Current Pharmaceutical Design Development of Aldose Reductase Inhibitors for the Treatment of Inflammatory Disorders and Cancer: Current Drug Design Strategies and Future Directions
Current Medicinal Chemistry Mitochondrial Dysfunction and Oxidative Stress in Insulin Resistance
Current Pharmaceutical Design Chaperones and Cardiac Misfolding Protein Diseases
Current Protein & Peptide Science Potential Therapeutic Effect of Antioxidant Therapy in Shock and Inflammation
Current Medicinal Chemistry Calcium Related Genes in Dogs as Potential Cardiac Biomarkers for the Detection of Chronic Mitral Valve Disease
Recent Patents on Biomarkers Ethnic and Geographical Differences in Ischaemic Stroke Among Young Adults
Current Vascular Pharmacology Impact of Diabetes on Cardiac and Vascular Disease: Role of Calcium Signaling
Current Medicinal Chemistry Preface
Current Cardiology Reviews The Proteasome in Health and Disease
Current Pharmaceutical Design Pleiotropic Effects of Fenofibrate
Current Pharmaceutical Design Aldosteronism in Heart Failure: A Proinflammatory / Fibrogenic Cardiac Phenotype. Search for Biomarkers and Potential Drug Targets
Current Drug Targets Regulation of Self-Reactive T Cells by Human Immunoglobulins- Implications for Multiple Sclerosis Therapy
Current Pharmaceutical Design GEMSP: A New Therapeutic Approach to Multiple Sclerosis
Central Nervous System Agents in Medicinal Chemistry